Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venu Menon

Showing results (251-260 of 347) with videos related to

Pageof 35
Sort By:
Pacing and Clinical Electrophysiology : PACE|January 26, 2019
Management and outcomes in mitral valve prolapse with ventricular arrhythmias undergoing ablation and/or implantation of ICDsJoseph M Bumgarner, Divyang Patel, Anirudh Kumar, et al.
Circulation|November 18, 2024
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and ObesityMichael R Zile, Barry A Borlaug, Christopher M Kramer, et al.
Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.
European Heart Journal. Acute Cardiovascular Care|May 11, 2021
Predictors of permanent pacemaker requirement after cardiac surgery for infective endocarditisTerence E Hill, Erich L Kiehl, Nabin K Shrestha, et al.
The American Journal of Medicine|July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION TrialDaniel H Solomon, M Elaine Husni, Peter A Libby, et al.
American Heart Journal|September 26, 2006
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trialC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.
The American Journal of Medicine|July 11, 2006
Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromesVenu Menon, John S Rumsfeld, Matthew T Roe, et al.
American Heart Journal|April 1, 2009
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trialWarren J Cantor, Sergio B Baptista, Vankeepuram S Srinivas, et al.
American Heart Journal|July 22, 2009
The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement InitiativeMauricio G Cohen, Steven J Filby, Matthew T Roe, et al.
The American Journal of Medicine|May 4, 2005
Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trialsMauricio G Cohen, Robert V Kelly, David F Kong, et al.
Pageof 35

Showing results (251-260 of 347) with videos related to

Sort By:
Pageof 35
Pacing and Clinical Electrophysiology : PACE|January 26, 2019
Management and outcomes in mitral valve prolapse with ventricular arrhythmias undergoing ablation and/or implantation of ICDsJoseph M Bumgarner, Divyang Patel, Anirudh Kumar, et al.
Circulation|November 18, 2024
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and ObesityMichael R Zile, Barry A Borlaug, Christopher M Kramer, et al.
Lancet (London, England)|March 14, 2015
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P Cannon, William C Cushman, et al.
European Heart Journal. Acute Cardiovascular Care|May 11, 2021
Predictors of permanent pacemaker requirement after cardiac surgery for infective endocarditisTerence E Hill, Erich L Kiehl, Nabin K Shrestha, et al.
The American Journal of Medicine|July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION TrialDaniel H Solomon, M Elaine Husni, Peter A Libby, et al.
American Heart Journal|September 26, 2006
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trialC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.
The American Journal of Medicine|July 11, 2006
Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromesVenu Menon, John S Rumsfeld, Matthew T Roe, et al.
American Heart Journal|April 1, 2009
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trialWarren J Cantor, Sergio B Baptista, Vankeepuram S Srinivas, et al.
American Heart Journal|July 22, 2009
The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement InitiativeMauricio G Cohen, Steven J Filby, Matthew T Roe, et al.
The American Journal of Medicine|May 4, 2005
Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trialsMauricio G Cohen, Robert V Kelly, David F Kong, et al.
Pageof 35